Breast Lesion Localization Methods Market Size & Forecast By Type (Wire Localization Biopsy, Radioisotope Localization, Radio-Guided Occult-lesion Localization (ROLL), Radioactive Seed Localization (RSL), Magnetic Tracer), And Trend Report

Breast Lesion Localization Methods Market Size & Forecast By Type (Wire Localization Biopsy, Radioisotope Localization, Radio-Guided Occult-lesion Localization (ROLL), Radioactive Seed Localization (RSL), Magnetic Tracer), And Trend Analysis, 2018 - 2025

  • Published Date: Jul, 2017
  • Base Year for Estimate: 2016
  • Report ID: GVR-1-68038-958-6
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 85

Industry Insights

The global breast lesion localization methods market size was valued at USD 507.7 million in the year 2016 and is estimated to reach a value of USD 1,577.6 million by 2025, growing at CAGR of 13.3%. Rising demand for better healthcare infrastructure and facilities as well as increasing awareness about mammary gland cancer screening are some of the key factors expected to boost the breast lesion localization methods market. 

Various government and nongovernment organizations, such as American Cancer Society, Canadian Breast Cancer Foundation, and National Breast Cancer Foundation, have undertaken initiatives and have arranged diagnostic campaigns for mammary gland cancer detection. The National Breast Cancer Foundation has launched many programs such as Early Detection Plan and Breast Health Education to provide patients with facilities for early diagnosis and care services.

U.S. breast lesion localization methods, by type, 2014 - 2025 (USD Billion)

U.S. breast lesion localization methods market

It was reported that around 252,710women & 2,470 men are expected to diagnose with invasive breast cancer and 40,610 women are expected to die from the condition in 2017. The survival rate in case of invasive type is 90% and 83% for five & ten years, respectively.

Mammary gland cancer surgery is an expensive procedure with its cost ranging from USD 8000 to 12000 for stage II and from USD 12000 to 18000 for stage III. The government has introduced favorable reimbursement policies to finance treatment and provide support to families of patients. For instance, the New York State Department of Health has launched an initiative called Cancer Services Program (CSP), which provides reimbursement for fine needle aspiration biopsy with ultrasound guidance. It also provides reimbursement for excisional biopsy, incisional biopsy, preoperative mammographic needle localization, and related services.

Type Insights

Breast lesion localization methods consist of various techniques such as wire localization biopsy, radioisotope localization, and magnetic tracers. Wire guided biopsy, also known as needle localization, is expected to dominate the market owing to its early development and higher adoption amongst end users. Widely used devices include RPLN, Duo System, Q-wire system, and X-Reidy. 

Magnetic tracers are expected to witness fastest growth over the forecast period owing to their enhanced efficacy due to introduction of novel mechanisms. For instance, the combination of the instrument, Sentimag probe and the magnetic tracer, Sienna+ helps in accurate & safe procedure. Furthermore, cost-effectiveness, improved surgical planning, and enhanced workflow management support the growth of this segment.

The continuous technological advancements of lesion localization devices is also considered to be a key driver propelling the market growth. For instance, SAVI SCOUT of Cianna Medical, Inc. is a surgical guidance system that uses electromagnetic waves to detect a reflector placed at the target site up to seven days before surgery. In addition, SOMATEX has launched many advanced devices such as Tumark Q and Q-Wire System for localization of lesions.

Global breast lesion localization methods, by region, 2016 (%)

Global breast lesion localization methods market

Regional Insights

North America is the dominant region of this market. It held the share of over 36.0% in 2016. Presence of key manufacturers in the U.S, established healthcare infrastructure, and high adoption of these procedures are some of the factors responsible for its large share. Moreover, favorable government initiatives and increasing number of breast conserving surgeries being performed are some of the drivers expected to fuel the market growth. 

Asia Pacific is estimated to witness the fastest growth over the next decade with CAGR of around 15.0% owing to the rising disposable income, high unmet clinical needs of patients, rising awareness about early diagnosis, and availability of effective treatment in emerging countries, such as India and China.

Competitive Insights

Key players in this industry are Cianna Medical; Cook Medical; STERYLAB; CP Medical, Inc.; SOMATEX Medical Technologies GmbH; Argon Medical Devices, Inc.; and C.R. BARD, Inc. 

Key players are focusing on expanding their businesses in developing regions to increase their market share. In addition, they are adopting strategies such as mergers & acquisitions and development of new products. For instance, in November 2015, SOMATEX launched new SXono needle guides. These needles provide guidance during tissue biopsies and follicular puncture.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Billion & CAGR from 2016 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, UK, Germany, Japan, China, India, Brazil, Mexico, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope(equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the market trends in each of the sub-markets from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the breast lesion localization methods market on the basis of type and region: 

  • Type Outlook (Revenue, USD Billion; 2014 - 2025)

    • Wire localization biopsy

    • Radioisotope localization

      • Radio guided occult-lesion localization (ROLL)

      • Radioactive-seed localization (RSL)

      • Other Radioisotope localization

    • Magnetic tracer

    • Others

  • Regional Outlook (Revenue, USD Billion; 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

    • Asia Pacific

      • China

      • Japan

      • India

    • Latin America

      • Mexico

      • Brazil

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Compass Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified